Literature DB >> 29363536

Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma.

Alex Y L Lee1, Claire L Dubois2, Karnjit Sarai1, Soheila Zarei1, David F Schaeffer3, Maike Sander2, Janel L Kopp1.   

Abstract

OBJECTIVE: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive tumour thought to arise from ductal cells via pancreatic intraepithelial neoplasia (PanIN) precursor lesions. Modelling of different genetic events in mice suggests both ductal and acinar cells can give rise to PDAC. However, the impact of cellular context alone on tumour development and phenotype is unknown.
DESIGN: We examined the contribution of cellular origin to PDAC development by inducing PDAC-associated mutations, KrasG12D expression and Trp53 loss, specifically in ductal cells (Sox9CreER;KrasLSL-G12D;Trp53flox/flox ('Duct:KPcKO ')) or acinar cells (Ptf1aCreER;KrasLSL-G12D;Trp53flox/flox ('Acinar:KPcKO ')) in mice. We then performed a thorough analysis of the resulting histopathological changes.
RESULTS: Both mouse models developed PDAC, but Duct:KPcKO mice developed PDAC earlier than Acinar:KPcKO mice. Tumour development was more rapid and associated with high-grade murine PanIN (mPanIN) lesions in Duct:KPcKO mice. In contrast, Acinar:KPcKO mice exhibited widespread metaplasia and low-grade as well as high-grade mPanINs with delayed progression to PDAC. Acinar-cell-derived tumours also had a higher prevalence of mucinous glandular features reminiscent of early mPanIN lesions.
CONCLUSION: These findings indicate that ductal cells are primed to form carcinoma in situ that become invasive PDAC in the presence of oncogenic Kras and Trp53 deletion, while acinar cells with the same mutations appear to require a prolonged period of transition or reprogramming to initiate PDAC. Our findings illustrate that PDAC can develop in multiple ways and the cellular context in which mutations are acquired has significant impact on precursor lesion initiation, disease progression and tumour phenotype. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  lineage tracing; pancreatic cancer; tumor development; tumor heterogeneity

Mesh:

Substances:

Year:  2018        PMID: 29363536     DOI: 10.1136/gutjnl-2017-314426

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  36 in total

Review 1.  The pancreatic cancer genome revisited.

Authors:  Akimasa Hayashi; Jungeui Hong; Christine A Iacobuzio-Donahue
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-04       Impact factor: 46.802

2.  Tobacco Carcinogen-Induced Production of GM-CSF Activates CREB to Promote Pancreatic Cancer.

Authors:  Supriya Srinivasan; Tulasigeri Totiger; Chanjuan Shi; Jason Castellanos; Purushottam Lamichhane; Austin R Dosch; Fanuel Messaggio; Nilesh Kashikar; Kumaraswamy Honnenahally; Yuguang Ban; Nipun B Merchant; Michael VanSaun; Nagaraj S Nagathihalli
Journal:  Cancer Res       Date:  2018-09-19       Impact factor: 12.701

3.  Increased expression of plakoglobin is associated with upregulated MAPK and PI3K/AKT signalling pathways in early resectable pancreatic ductal adenocarcinoma.

Authors:  Ekene Nweke; Monde Ntwasa; Martin Brand; John Devar; Martin Smith; Geoffrey Candy
Journal:  Oncol Lett       Date:  2020-03-23       Impact factor: 2.967

Review 4.  Cell Type of Pancreatic Ductal Adenocarcinoma Origin: Implications for Prognosis and Clinical Outcomes.

Authors:  Shilpa Patil; Yan Dou; Janel L Kopp
Journal:  Visc Med       Date:  2021-12-27

Review 5.  Molecular signaling in pancreatic ductal metaplasia: emerging biomarkers for detection and intervention of early pancreatic cancer.

Authors:  Xiaojia Li; Jie He; Keping Xie
Journal:  Cell Oncol (Dordr)       Date:  2022-03-15       Impact factor: 6.730

Review 6.  The cellular origins of cancer with particular reference to the gastrointestinal tract.

Authors:  Malcolm R Alison
Journal:  Int J Exp Pathol       Date:  2020-08-14       Impact factor: 1.925

7.  Cell of Origin Influences Pancreatic Cancer Subtype.

Authors:  Brittany M Flowers; Hang Xu; Abigail S Mulligan; Kathryn J Hanson; Jose A Seoane; Hannes Vogel; Christina Curtis; Laura D Wood; Laura D Attardi
Journal:  Cancer Discov       Date:  2021-03       Impact factor: 39.397

8.  Single-cell transcriptome analysis defines heterogeneity of the murine pancreatic ductal tree.

Authors:  Arjun A Rao; Laura Leonhardt; Sudipta Ashe; Audrey M Hendley; Jennifer A Smith; Simone Giacometti; Xianlu L Peng; Honglin Jiang; David I Berrios; Mathias Pawlak; Lucia Y Li; Jonghyun Lee; Eric A Collisson; Mark S Anderson; Gabriela K Fragiadakis; Jen Jen Yeh; Chun Jimmie Ye; Grace E Kim; Valerie M Weaver; Matthias Hebrok
Journal:  Elife       Date:  2021-05-19       Impact factor: 8.713

9.  A genome-wide library of MADM mice for single-cell genetic mosaic analysis.

Authors:  Ximena Contreras; Nicole Amberg; Amarbayasgalan Davaatseren; Andi H Hansen; Johanna Sonntag; Lill Andersen; Tina Bernthaler; Carmen Streicher; Anna Heger; Randy L Johnson; Lindsay A Schwarz; Liqun Luo; Thomas Rülicke; Simon Hippenmeyer
Journal:  Cell Rep       Date:  2021-06-22       Impact factor: 9.423

10.  SOX9 modulates cancer biomarker and cilia genes in pancreatic cancer.

Authors:  Hannah E Edelman; Sarah A McClymont; Tori R Tucker; Santiago Pineda; Rebecca L Beer; Andrew S McCallion; Michael J Parsons
Journal:  Hum Mol Genet       Date:  2021-04-30       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.